Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02846870 · ClinicalTrials.gov registry record · NA

Visually Enhanced Education About Prostate Cancer

A NA study of Stage I Prostate Cancer and Stage III Prostate Cancer, sponsored by Vanderbilt-Ingram Cancer Center.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT02846870 is a NA study of Stage I Prostate Cancer and Stage III Prostate Cancer that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 30 participants, below the 57-participant average among 9 other Stage I Prostate Cancer trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02846870, a NA study of Stage I Prostate Cancer and Stage III Prostate Cancer, has completed, sponsored by Vanderbilt-Ingram Cancer Center.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This randomized clinical trial studies how well visually enhanced education works in improving prostate cancer and treatment knowledge in patients with prostate cancer that has not spread to other places in the body. Visually enhanced education includes pictures, drawings, and photos, may help doctors better convey information about radiation and prostate cancer to patients.

Interventions

  • OTHER Visually enhanced prostate cancer educational presentation
  • OTHER Standard prostate cancer education presentation

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2016-09
Est. Completion 2018-08
Phase NA

Sponsor

Vanderbilt-Ingram Cancer Center

189 total trials

What the Registry Record Tells You About NCT02846870

The ClinicalTrials.gov registry entry for NCT02846870 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 57-participant average among 9 other Stage I Prostate Cancer trials with a reported enrollment target (47% lower). The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Stage I Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Visually enhanced prostate cancer educational presentation is the first listed.

NCT02846870 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT02846870 about?

NCT02846870 is a clinical study titled "Visually Enhanced Education About Prostate Cancer". This randomized clinical trial studies how well visually enhanced education works in improving prostate cancer and treatment knowledge in patients with prostate cancer that has not spread to other places in the body. Visually enhanced education includes pictures, drawings, and photos, may help docto...

What is the current status of trial NCT02846870?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-09. Estimated completion is 2018-08.

What conditions does trial NCT02846870 study?

This clinical trial studies the following conditions: Stage I Prostate Cancer, Stage III Prostate Cancer, Stage II Prostate Cancer.

What interventions are being tested in trial NCT02846870?

The interventions under investigation include: Visually enhanced prostate cancer educational presentation (OTHER), Standard prostate cancer education presentation (OTHER).

Who is sponsoring clinical trial NCT02846870?

This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02846870 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stage I Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.